THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
31.230 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
31.230 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
31.230 |
Evidence |
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
31.230 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CDK5 |
CDK5: Cell division protein kinase 5 |
31.230 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
31.230 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PIK3CB |
PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit |
31.230 |
Evidence |
|
IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
31.230 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
HPCAL1 |
HPCAL1, BDR1: Hippocalcin-like protein 1 |
31.230 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
31.230 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
ROBO1 |
ROBO1, DUTT1: Roundabout homolog 1 precursor |
31.230 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
31.230 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
CRKL |
CRKL: Crk-like protein |
31.230 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
31.230 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
31.230 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
VAV3 |
VAV3: Protein vav-3 |
31.180 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SHB |
SHB: SH2 domain-containing adapter protein B |
31.180 |
Evidence |
|
STX12 |
STX12: Syntaxin-12 |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
31.180 |
Evidence |
|
LMNA |
LMNA, LMN1: Lamin-A/C |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
31.110 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
31.110 |
Evidence |
|
LMNA |
LMNA, LMN1: Lamin-A/C |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
31.110 |
Evidence |
|
ARHGEF7 |
IPI00449908 |
GIT2 |
IPI00238218 |
31.110 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
31.110 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
31.110 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
31.110 |
Evidence |
|